On the afternoon of June 23, the “Salute to 40 Years” held by the Shenzhen Chamber of Commerce, Shenzhen Chamber of Commerce, and the top ten industrial alliances of Shenzhen Chamber of Commerce Decisive Victory in the Post-Epidemic Era” The 2020 First Shenzhen High-Tech and High-Tech Growth Forum was successfully held at the Shenzhen Kexing Science Park International Conference Center. Dr. Hu Junyuan, chairman of Beike Biotechnology, was invited to attend and deliver a keynote speech on “Breakthrough·Reconstruction” as the executive chairman of the Shenzhen Business Life and Health Industry Alliance.
As one of the core sub-forums of this summit forum, the “Real Heroes in the Fight against the Epidemic, High-tech Breakthrough” forum has attracted much attention. It invited many big names in the industry to gather together to talk about the highlight moments of technology in fighting the “epidemic”, to discover new opportunities for enterprises in the crisis, and to create new situations in the changing situation.
At the sub-forum, Dr. Hu Junyuan, chairman of Beike Biotech, gave a wonderful speech with the theme of “Breakthrough·Reconstruction”. He and the guests present conducted an in-depth interpretation of the current frontier fields of life sciences and biomedicine industries around the three cores of “people”, “technology” and “life”. He also talked about the breakthrough progress and results achieved by stem cells in the treatment of severe COVID-19 patients in the fight against the epidemic, and demonstrated the work and results of Beike Biotech in the fight against the new coronavirus epidemic.
Dr. Hu’s wonderful speech made the guests present feel the charm of biotechnology, and also full of hope for the future development of biomedicine and cell therapy.
As a national high-tech enterprise specializing in the clinical transformation of personalized cell therapy technology, Beike Biotech has been committed to becoming a leading company in promoting the clinical transformation of cell therapy technology. The Shenzhen Comprehensive Cell Bank, established and operated by Beike Biotechnology, is a life and health industry infrastructure in Shenzhen approved by the Shenzhen Municipal Development and Reform Commission. Currently, Beike Biotech has established a business structure of “1 bank, 1 center, 1 platform” (comprehensive cell bank + regional cell preparation center + cell quality testing platform), and provides cell resource storage, preparation, testing and other services in many provinces and cities in China.
In terms of medical health, Beike Biotech began to conduct systematic research and new drug development on a variety of refractory diseases in 2009, including process verification, quality research, stability research, pharmacology research, toxicology research, etc. of mesenchymal stem cells. Among them, the research results of “Key technological innovation and clinical application of allogeneic mesenchymal stem cells in the treatment of refractory lupus erythematosus” have won The honor of the 2019 National Technology Invention Award; At the same time, after the outbreak of the new coronavirus epidemic this year, Beike Biotech responded immediately and won the “New coronavirus infection prevention and control scientific and technological emergency response project” was established, and the Kunming Science and Technology Bureau’s new coronavirus infection pneumonia scientific and technological prevention and control special project was established; in May this year, the product independently developed by Beike Biotechnology “The new drug clinical registration application for human umbilical cord mesenchymal stem cells for injection in the treatment of refractory systemic lupus erythematosus” was officially accepted by the Review Center of the State Food and Drug Administration, becoming the first domestic stem cell product for the treatment of refractory systemic lupus erythematosus.
It is reported that this forum is to pay tribute to the 40 years of construction of the Shenzhen Special Economic Zone, to assist the construction of the dual zones, to boost the confidence of entrepreneurs in the development, and to unite Shenzhen businessmen to explore new models and new ideas for industrial innovation and upgrading in the post-epidemic era. The forum attracted nearly 200 people, including heads of well-known Shenzhen business enterprises, experts and scholars, and media reporters.